Adenoviral vectors efficiently target cell lines derived from selected lymphocytic malignancies, including anaplastic large cell lymphoma and Hodgkin's disease

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 357-364

  Meeker, Timothy C ^a,c   Lay, L Travis ^a   Wroblewski, Joanne M ^a   Turturro, Francesco ^a   Li, Zhuangwe ^b   Seth, Prem ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOTOXICITY; FLOW CYTOMETRY; GENE THERAPY; GENETIC TRANSDUCTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; PRIORITY JOURNAL;

ADENOVIRIDAE; ANTIVIRAL AGENTS; BETA-GALACTOSIDASE; BURKITT LYMPHOMA; CELL SURVIVAL; GANCICLOVIR; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HERPESVIRUS 1, HUMAN; HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA; LYMPHOMA, LARGE B-CELL, DIFFUSE; LYMPHOMA, LARGE-CELL; MULTIPLE MYELOMA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECOMBINANT FUSION PROTEINS; THYMIDINE KINASE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030933720     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kozarsky, K., and Wilson, J. Gene Therapy. Adenoviral Vectors. Curr. Opin. Genet. Dev., 3: 499-503, 1993.
2. Perricaudet, M., and Stratford-Perricaudet, L. Adenovirus-mediated in vivo gene therapy. In: J. Vos (ed.), Viruses in Human Gene Therapy, pp. 1-32. Durham: Chapman and Hall, 1995.
3. Wilson, J. Adenoviruses as gene-delivery vehicles. N. Engl. J. Med., 334: 1185-1187, 1996.
4. Brody, S., and Crystal, R. Adenovirus-mediated in vivo gene therapy. Ann. NY Acad. Sci., 716: 90-103, 1993.
5. Faucon, N., and Desgranges, C. Persistence of human adenovirus 5 in human cord blood lymphoblastoid cell lines transformed by Epstein-Barr virus. Infect. Immun., 29: 1180-1184, 1980.
6. Silver, L., and Anderson, C. Interaction of human adenovirus serotype 2 with human lymphoid cells. Virology, 765: 377-387, 1988.
7. Lavery, D., Fu, S., Lufkin, T., and Chen-Kiang, S. Productive infection of cultured human lymphoid cells by adenovirus. J. Virol., 67: 1466-1472, 1987.
8. Wattel, E., Vanrumbeke, M., Abina, M., Cambier, N., Preudhomme, C., Haddada, H., and Fenaux, P. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia (Baltimore), 70: 171-174, 1996.
9. Faucon, N., Chardonnet, Y., Perrinet, M., and Sohier, R. Superinfection with adenovirus of Burkitts lymphoma cell lines. J. Natl. Cancer Inst., 53: 305-308, 1974.
10. Lambriex, M., and Veen, J. Comparison of replication of adenovirus type 2 and type 4 in human lymphocyte cultures. Infect. Immun., 14: 618-622, 1976.
11. Andiman, W., and Miller, G. Persistent infection with adenovirus types 5 and 6 in lymphoid cells from humans and wooly monkeys, J. Infect. Dis., 145: 83-88, 1982.
12. Strohl, W., and Schlesinger, R. Quantitative studies of natural and experimental adenovirus infections of human cells. Virology, 26: 208-220, 1965.
13. O'Malley, B., Chen, S., Schwanz, M., and Woo, S. Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res., 55: 1080-1085, 1995.
14. Moolten, F., and Wells, J. Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J. Natl. Cancer Inst., 82: 297-300, 1990.
15. Culver, K., Ram, Z., Wallbidge, S., Ishii, H., Oldfield, E., and Blaese, R. M. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
16. Wills, K., Maneval, D., Menzel, P., Harris, M., Sutjipto, S., Vaillancourt, M., Huang, W., Johnson, D., Anderson, S., Wen, S., Bookstein, R., Shepard, H., and Gregory, R. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer. Hum. Gene Ther., 5: 1079-1088, 1994.
17. Jin, X., Nguyen, D., Zhang, W., Kyritsis, A., and Roth, J. Cell cycle arrest and inhibition of tumor cell proliferation by the p16-INK4 gene mediated by an adenovirus vector. Cancer Res., 55: 3250-3253, 1995.
18. Liu, J., El-Maggar, A., McDonnell, T., Steck, K., Wang, M., Taylor, D., and dayman, G. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res., 55: 3117-3122, 1995.
19. Katayose, D., Wersto, R., Cowan, K., and Seth, P. Effects of a recombinant adenovirus expressing WAF1/Cipl on cell growth, cell cycle, and apoptosis. Cell Growth & Differ., 6: 1207-1212, 1995.
20. Meeker, T. C., Sellers, W., Harvey, R., Withers, D., Carey, K., Xiao, H., Block, A., Dadey, B., and Han, T. Cloning of the t(l l;14)(q13; q32) translocation breakpoints from two human leukemia cell lines. Leukemia (Baltimore), 5: 733-737, 1991.
21. Minowada, J. Immunology of leukemic cells. In: F. Gunz and E. Henderson (eds.), Leukemia, pp. 119-139. New York: Grune and Stratum, 1983.
22. Epstein, A., Levy, R., Kirn, H., Henle, W., Henle, G., and Kaplan, H. Biology of the human malignant lymphomas. IV. Functional characterization of ten histiocytic lymphoma cell lines. Cancer (Phila.), 42: 2379-2389, 1978.
23. Pasqualucci, L., Wasik, M., Teicher, B., Flenghi, L., Bolognesi, A., Stirpe, F., Polito, L., Falini, B., and Kadi n, M. Antitumor activity of anti-CD30 immunotoxin in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large cell lymphoma. Blood, 55: 2139-2146, 1995.
24. Saltman, D. L., Cacnia, P. G., Dewar, A. E., Ross, F. M., Krajewski, A. S., Ludlam, C., and Steel, C. M. Characterization of a new nonHodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11;14) translocation [t(11;14)(q13;q32)]. Blood, 72: 2026-2030, 1988.
25. Nacheva, E., Fischer, P. E., Shemngton, P. D., Labastide, W., Lawlor, E., Conneally, E., Blaney, C., Hayhoe, F. G. J., Karpas, A. A new plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11, and 14, Br. J. Haematol., 74: 70-76, 1990.
26. Matsuoka, Y., Moore, G. E., Yagi, Y., and Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med., 725: 1246-1250, 1967.
27. Engelhardt, J., Ye, X., Doranz, B., and Wilson, J. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA, 91: 6196-6200, 1994.
28. Rosenfeld, M., Feng, M., Michael, S., Siegal, G., Alvarez, R., and Curiel, D. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Clin. Cancer Res., 1: 1571-1580, 1995.
29. Katayose, D., Gudas, J., Nguyen, H., Srivastava, S., Cowan, K., and Seth, P. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res., 1: 889-897, 1995.
30. Wroblewski, J., Lay, L., Van Zant, G., Phillips, G., Seth, P., Curiel, D., and Meeker, T. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus. Cancer Gene Ther., 3: 257-264, 1996.
31. Graham, F., and Prevec, L. Manipulation of adenovirus vectors, In: E. Murray (ed.), Gene Transfer and Expression Protocols, pp. 109-128. Clifton, NJ: Humana Press, 1991.
32. Cannella, M., and Ross, R. Influence of substratum on the retrograde response of the rat superior cervical ganglion in vitro. Exp. Neurol., 95: 652-660, 1987.
33. Sanes, J., Rubenstein, J., and Nicolas, J. Use of a recombinant retro virus to study post-implantation cell lineage in mouse embryos. EMBO J., 5: 3133-3142, 1986.
34. Zhang, Y., Naleway, J., Larison, K., Huang, Z., and Haugland, R. Detecting lacZ gene expression in living cells with new lipophilic, fluorogenic β-galactosidase substrates. FASEB J., 5: 3108-3113, 1991.
35. Nolan, G., Fiering, S., Nicolas, J., and Herzenberg, L. Fluorescenceactivated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc. Natl. Acad. Sci. USA, 85: 2603-2607, 1988.
36. Fiering, S., Roederer, M., Nolan, G., Micklem, D., Parks, D., and Herzenberg, L. Improved FACS-Gal: flow cytometric analysis and sorting of viable eukaryotic cells expressing reporter gene constructs, Cytometry, 12: 291-301, 1991.
37. Menezes, J., Leibold, W., Klein, G., and Clements, G. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genomenegative African Burkitts lymphoma. Biomedicine, 22: 276-284, 1975.
38. Sambrook, J., Fritsch, E., and Maniatis, T. Molecular Cloning: A Laboratory Manual, pp. 16.1-16.81. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.